Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2009-12-24 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
CONTINUING CONNECTED TRANSACTION IN RESPECT OF RENEWAL OF LEASE OF PROPERTIES
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a continuing connected transaction related to the renewal of a lease agreement between the company and a connected party. It details the terms of the tenancy agreement, rental amounts, and the relationship between the parties involved. The document is structured as a formal announcement to shareholders and the public, referencing compliance with Listing Rules and reporting requirements. It does not contain financial statements, audit information, or detailed financial performance data. It is not a report but an announcement of a specific corporate transaction related to leasing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2009-12-24 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Overseas Chinese Town (Asia) Holdings Limited. It includes details about the meeting date, location, agenda items such as approval of capital increase agreements, share allotment mandates, and share repurchase mandates. The document is a formal announcement inviting shareholders to attend and vote on resolutions at the EGM. It does not contain financial statements, audit information, or detailed management discussion. It is not a report but a meeting notice. Therefore, the appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during general meetings, including notices of meetings.
2009-12-22 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Overseas Chinese Town (Asia) Holdings Limited. It includes details about the meeting date, location, agenda items such as approval of capital increase agreements, share allotment mandates, and share repurchase mandates. The document is a formal announcement inviting shareholders to attend and vote on resolutions at the EGM. It does not contain financial statements, audit information, or detailed management discussion. It is not a report but a meeting notice. Therefore, the appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during general meetings, including notices of meetings.
2009-12-22 English
FORM OF PROXY FOR USE AT THE ENTRAORDINARY GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of Overseas Chinese Town (Asia) Holdings Limited. It contains instructions for shareholders to appoint proxies to vote on resolutions related to capital increase agreements, joint venture agreements, and general mandates for share allotment and repurchase. The content is procedural and related to shareholder voting at a meeting, not a report or announcement of financial results or management changes. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for a meeting.
2009-12-22 English
(A) DISCLOSEABLE AND CONNECTED TRANSACTION - CAPITAL INJECTION TO XI'AN OCT INVESTMENT&#x3b; AND (B) PROPOSED REFRESHMENT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular issued by Overseas Chinese Town (Asia) Holdings Limited dated 23 December 2009. It contains detailed information about a discloseable and connected transaction involving a capital injection to Xi’an OCT Investment and a proposed refreshment of general mandates to issue and repurchase shares. It includes letters from the Board, Independent Board Committee, and Independent Financial Adviser, explanatory statements, general information, and a notice of an extraordinary general meeting (EGM) to be held on 12 January 2010. The document is comprehensive and intended to inform shareholders about the transaction and seek their approval at the EGM. This type of document is typically classified as a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the EGM resolutions. It is not an announcement, earnings release, or a report like an annual or interim report. The length (15,000 characters) and content confirm it is a full circular with detailed information for shareholder decision-making.
2009-12-22 English
TERMINATION OF THE WUHAN CAPITAL INCREASE AGREEMENT AND THE WUHAN JOINT VENTURE AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the termination of previously announced agreements related to a capital increase and joint venture. It references a prior announcement dated 7 December 2009 and details the termination agreement signed on 14 December 2009. The content focuses on the cessation of a transaction and its impact on the company, without providing financial statements or detailed financial data. The document is relatively short (3966 characters) and serves as a regulatory announcement about a transaction termination rather than a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2009-12-14 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.